Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.18

+2.4%

12:52 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob smith who wrote (14083)	2/2/1998 6:24:00 PM
From: Henry Niman	Read Replies (2) of 32384

Bob, CNBC's The Edge just had Brian Finnerty and Vincent Farrel on. Not surprisingly, the discussion turned to today's big move by the pharmas. Both analysts were in agreement on the superiority of Biotech over big pharmas. They noted that today's merger mania was being fueled for a large R&D requirement, but they compared big pharma valuations to Biotechs. MRK's market cap is $140 Billion and they spend $1.5 Billion on R&D. In contrast, all Biotechs combined had a market cap of $85 Billion with $5 Billion spent on R&D. Thus they both agreed that Biotechs were a much better value for the long term investor.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next